Search

everythinglearnresearchcommunity

for

Search:↓

Two brothers from Bangladesh were diagnosed with X-linked adrenoleukodystrophy, showing neurological and adrenal symptoms.

Efficient enzyme function relies on specific residue interactions and structural coordination.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

New gene variants linked to a rare inherited hair loss disorder were found in three Chinese families.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Msx and Dlx genes are crucial for development, controlling cell behaviors like growth and differentiation through their roles as gene regulators.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Royal jelly can protect the heart from damage caused by paclitaxel.

Krox20 (Egr2) is important for the function of epithelial stem cells.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

ISX-9 helps stem cells heal lung injury better by boosting growth factor secretion.

MK-5108 is safe and shows potential against tumors, especially alone.

A new mutation in the ST14 gene broadens the understanding of ichthyosis-hypotrichosis syndrome.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

A new gene variant causes curly coats in some dog breeds.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Ruxolitinib treatment may cause eyelash growth.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.